R&G PharmaStudies Co., Ltd. (SHE:301333)
China · Delayed Price · Currency is CNY 50.70
+3.38 (7.14%)
At close: Aug 4, 2026
-9.46% (1Y)
| Market Cap | 4.87B -8.7% |
| Revenue (ttm) | 896.26M +21.2% |
| Net Income | 133.65M -6.7% |
| EPS | 1.40 -6.5% |
| Shares Out | 95.99M |
| PE Ratio | 36.18 |
| Forward PE | 29.31 |
| Dividend | 0.16 (0.34%) |
| Ex-Dividend Date | Jul 3, 2026 |
| Volume | 4,128,499 |
| Open | 48.38 |
| Previous Close | 47.32 |
| Day's Range | 48.12 - 51.20 |
| 52-Week Range | 43.79 - 91.78 |
| Beta | 0.39 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |